Molecular Docking, Synthesis, Characterization and Preliminary Evaluation of some New 3-Ethyl-1𝐻-Indole Derivatives as Potential COX-2 Inhibitors
نویسندگان
1 Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
2 Department of Pharmaceutical Chemistry, College of Pharmacy, Kerbala University, Karbala, Iraq
doi
10.48309/ajca.2025.482848.1712چکیده
Selective cyclooxygenase-2 inhibitors have gained prominence in anti-inflammatory drug development due to their potential to reduce inflammation while minimizing the gastrointestinal toxicity associated with non-selective NSAIDs. This study focuses on the synthesis, molecular docking, characterization, and evaluation of new 3-ethyl-1H-indole derivatives containing imidazolidinone pharmacophores as selective COX-2 inhibitors aimed at improving GI safety. Molecular docking studies predicted strong binding affinities for the synthesized compounds, with scores ranging from -11.35 to -10.40 kcal/mol, significantly higher than the reference drug meloxicam (-6.89 kcal/mol). The compounds were structurally confirmed using FT-IR and ¹H-NMR spectroscopy. ADME predictions further validated the drug-likeness and favorable pharmacokinetic profiles of the synthesized compounds. Preliminary in vivo anti-inflammatory activity was assessed using an egg-white-induced paw edema model in rats, where the compounds significantly reduced inflammation compared to ibuprofen. Compound IIb demonstrated the highest efficacy, with a prolonged reduction in paw edema. These findings indicate that the newly synthesized indole derivatives have potential as selective COX-2 inhibitors with promising anti-inflammatory properties and improved GI safety. Future studies will focus on further toxicity and enzymatic inhibition assays to fully characterize their safety and therapeutic potential.